Related Experiment Video
Updated: May 10, 2026
09:14
An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
Published on: January 26, 2019
A neutralization assay for respiratory syncytial virus using a quantitative PCR-based endpoint assessment
Jan C Varada1, Belete Teferedegne, R Lynne Crim
1Laboratory of DNA Viruses, Division of Viral Products, OVRR, CBER, FDA, Bethesda, MD 20892, USA.
Virology Journal
|June 18, 2013
Summary
A new quantitative polymerase chain reaction (qPCR) assay simplifies virus neutralization testing for respiratory syncytial virus (RSV). This method streamlines analysis, enabling faster, high-throughput screening for potential antiviral therapies.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Quantitative polymerase chain reaction (qPCR) is underutilized for virus neutralization assays due to complex sample processing.
- Traditional methods involving nucleic acid extraction are costly and time-consuming.
Purpose of the Study:
- To develop and validate a streamlined qPCR-based virus neutralization assay.
- To establish a rapid and robust method for measuring neutralizing antibody responses.
Main Methods:
- A one-step SYBR Green qPCR assay was developed targeting the RSV-N gene.
- Cell lysates were directly analyzed, bypassing RNA extraction and purification.
- Neutralization was determined by the 90% inhibition of the PCR signal.
Main Results:
- A sensitive qPCR-based neutralization assay for respiratory syncytial virus (RSV) was successfully established.
- Assay endpoints can be determined as early as 24 hours post-infection.
- The assay demonstrates robustness to variations in viral input, adhering to the Percentage Law.
Conclusions:
- The developed qPCR assay is suitable for automated, high-throughput screening.
- This approach offers a generalizable platform for developing rapid neutralization assays for diverse viruses.
